Scynexis (SCYX) Gains from Sales and Divestitures (2022 - 2026)
Scynexis (SCYX) reported Gains from Sales and Divestitures of $1.1 million for Q1 2026, up 10.62% on a YoY basis from $1.0 million in Q1 2025, and down 4.69% quarter-over-quarter from $1.2 million in Q4 2025.
Scynexis (SCYX) Gains from Sales and Divestitures (2022 - 2026) Analysis & Trends
Scynexis has reported Gains from Sales and Divestitures for 5 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures rose 10.62% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 10.62% YoY), and the FY2025 full-year result was $1.2 million, up 63.42% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $1.1 million, down from $1.2 million in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $1.2 million in Q4 2025, with the low at $48131.0 in Q3 2022.
- Historically, Gains from Sales and Divestitures has averaged $636520.3 across 5 years, with a median of $629849.0 in 2024.
- Annual changes were most pronounced in 2023 — Gains from Sales and Divestitures soared 516.67% — and 2026, when it advanced 10.62%.
- Scynexis' Gains from Sales and Divestitures stood at $117831.0 in 2022, then jumped by 156.78% to $302561.0 in 2023, then jumped by 138.17% to $720599.0 in 2024, then surged by 63.42% to $1.2 million in 2025, then fell by 4.69% to $1.1 million in 2026.
- The last three Gains from Sales and Divestitures figures came in at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Scynexis | 216.06 Mn | 156.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.12 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 720,599.00 |
| Dec 31, 2024 | 720,599.00 |
| Sep 30, 2024 | 689,849.00 |
| Sep 30, 2024 | 689,849.00 |
| Jun 30, 2024 | 629,849.00 |
| Jun 30, 2024 | 629,849.00 |
| Mar 31, 2024 | 553,182.00 |
| Mar 31, 2024 | 553,182.00 |
| Dec 31, 2023 | 302,561.00 |
| Dec 31, 2023 | 302,561.00 |